Biomarkers - which may be enzymes, hormones, biologic substances, or other markers of cardiac stress and malfunction - appear to have growing clinical importance in heart failure. Many biomarkers appear to provide important information about the cause of heart failure or the identification of those at risk for heart failure or appear to be useful in risk stratification, in the diagnosis of heart failure, or in monitoring therapy. This issue discusses the current and potential future role of biomarkers and includes articles that explore individual biomarkers in depth.
| Editorial |
|
ix | |
|
|
|
|
| Preface |
|
xiii | |
|
|
|
What We May Expect from Biomarkers in Heart Failure |
|
|
463 | (8) |
|
|
|
Natriuretic Peptides: Physiologic and Analytic Considerations |
|
|
471 | (18) |
|
|
|
|
|
Natriuretic Peptides in the Diagnosis and Management of Acute Heart Failure |
|
|
489 | (12) |
|
|
|
|
|
Natriuretic Peptides in the Diagnosis and Management of Chronic Heart Failure |
|
|
501 | (14) |
|
|
|
Lisa C. Costello-Boerrigter |
|
|
|
|
ST2 and Adrenomedullin in Heart Failure |
|
|
515 | (14) |
|
|
|
|
|
Biomarkers of Myocyte Injury in Heart Failure |
|
|
529 | (8) |
|
|
|
|
|
Growth-Differentiation Factor-15 in Heart Failure |
|
|
537 | (12) |
|
|
|
|
|
Inflammatory Biomarkers in Heart Failure Revisited: Much More than Innocent Bystanders |
|
|
549 | (12) |
|
|
|
|
|
|
|
|
|
|
|
Biomarkers of Oxidative Stress in Heart Failure |
|
|
561 | (18) |
|
|
|
|
|
Newer Biomarkers in Heart Failure |
|
|
579 | (10) |
|
|
|
|
|
|
|
Biomarkers of Extracellular Matrix Turnover |
|
|
589 | (12) |
|
|
|
|
| Index |
|
601 | |
Dr. Eugene Braunwald, an Elsevier Author, is considered the leading name in cardiology and his research has expanded knowledge and understanding in the areas of congestive heart failure, coronary artery disease, and valvular heart disease. He has authored more than 1400 medical articles and his textbook, Braunwald's Heart Disease, is cited worldwide and recognized as the best book on the subject.
